87 related articles for article (PubMed ID: 32272221)
1. Host proteases as determinants of coronaviral neurotropism and virulence.
Vavougios GD
Brain Behav Immun; 2020 Jul; 87():27. PubMed ID: 32272221
[No Abstract] [Full Text] [Related]
2. Novel Coronavirus Disease (COVID-19) and Central Nervous System Complications: What Neurologist Need to Know.
Paybast S; Emami A; Koosha M; Baghalha F
Acta Neurol Taiwan; 2020 Mar; 29(1)():24-31. PubMed ID: 32285431
[TBL] [Abstract][Full Text] [Related]
3. Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system?
Bongetta D; Calloni T; Colombo EV; Versace A; Assietti R
Brain Behav Immun; 2020 Aug; 88():35. PubMed ID: 32446945
[No Abstract] [Full Text] [Related]
4. Targeting Proteases for Treating COVID-19.
Luan B; Huynh T; Cheng X; Lan G; Wang HR
J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
6. The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2.
Sun T; Guan J; You C
Brain Behav Immun; 2020 Aug; 88():59. PubMed ID: 32497777
[No Abstract] [Full Text] [Related]
7. Letter to the Editor: Is Coronavirus Disease 2019 A Real Threat to the Nervous System?
Sun T; Guan J
World Neurosurg; 2020 Nov; 143():631. PubMed ID: 33167154
[No Abstract] [Full Text] [Related]
8. Neurotropism of SARS-CoV 2: Mechanisms and manifestations.
Conde Cardona G; Quintana Pájaro LD; Quintero Marzola ID; Ramos Villegas Y; Moscote Salazar LR
J Neurol Sci; 2020 May; 412():116824. PubMed ID: 32299010
[No Abstract] [Full Text] [Related]
9. Can the enteric nervous system be an alternative entrance door in SARS-CoV2 neuroinvasion?
Esposito G; Pesce M; Seguella L; Sanseverino W; Lu J; Sarnelli G
Brain Behav Immun; 2020 Jul; 87():93-94. PubMed ID: 32335192
[No Abstract] [Full Text] [Related]
10. Nervous system damage after COVID-19 infection: Presence or absence?
Wu Y; Xu X; Yang L; Liu C; Yang C
Brain Behav Immun; 2020 Jul; 87():55. PubMed ID: 32311495
[No Abstract] [Full Text] [Related]
11. Cranial neuropathies and COVID-19: Neurotropism and autoimmunity.
Costello F; Dalakas MC
Neurology; 2020 Aug; 95(5):195-196. PubMed ID: 32487714
[No Abstract] [Full Text] [Related]
12. Sars-Cov-2: Underestimated damage to nervous system.
Zhou L; Zhang M; Wang J; Gao J
Travel Med Infect Dis; 2020; 36():101642. PubMed ID: 32220634
[No Abstract] [Full Text] [Related]
13. Neurological manifestations of SARS-CoV-2 - a systematic review.
Słyk S; Domitrz I
Neurol Neurochir Pol; 2020; 54(5):378-383. PubMed ID: 32667047
[TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vertical Transmission in Neonates Born to Mothers With Coronavirus Disease 2019 (COVID-19) Pneumonia.
Malhotra Y; Rossberg MC; Bajaj K; Shtern A; Moore RM
Obstet Gynecol; 2020 Sep; 136(3):632-633. PubMed ID: 32826580
[No Abstract] [Full Text] [Related]
15. Important considerations regarding the future management of coronavirus (COVID-19).
Abbas AR; Abbas A; Ali Y; Memon SF
Int J Surg; 2020 Jul; 79():6-7. PubMed ID: 32387212
[No Abstract] [Full Text] [Related]
16. Does active smoking worsen Covid-19?
Carmona-Bayonas A; Jimenez-Fonseca P; Sánchez Arraez Á; Álvarez Manceñido F; Castañón E
Eur J Intern Med; 2020 Jul; 77():129-131. PubMed ID: 32507518
[TBL] [Abstract][Full Text] [Related]
17. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
18. Treatments for COVID-19: emerging drugs against the coronavirus.
Khademolhosseini S; Kavandi H; Ghaffari S
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921740
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: in the absence of vaccination - 'mask the nation'.
Sleator RD; Darby S; Giltinan A; Smith N
Future Microbiol; 2020 Jul; 15():963-966. PubMed ID: 32677846
[No Abstract] [Full Text] [Related]
20. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
Potì F
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
